Market Tracker

07/25 6:05pm ET

SPDR S&P Pharmaceuticals ETF (XPH)

Data as of 3:59pm ET
 -0.89 / -0.89%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR S&P Pharmaceuticals ETF.


1 month-2.70% 3 years+26.36%
3 months+5.55% 5 years+28.06%
1 year+38.09% Since inception+16.96%
Data through 07/25/2014

Quote Details

Previous close$99.75
Open day’s range98.66 – 99.51
Net asset value (NAV)99.82 (07/24/2014)
Daily volume57,870
Average volume (3 months)81,121
Data as of 3:59pm ET, 07/25/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+28.06%+24.14%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio1.881.52
Net assets$948.9M$1.4B
Average market cap$7.9B$25.9B
Average P/E30.526.1
Dividend / Share--0.21%


VHT Vanguard Health Care ETF
XLV Health Care Select Sector SPDR┬« Fund
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AKRX Akorn Inc3.78%
THRX Theravance Inc3.67%
PCRX Pacira Pharmaceuticals Inc3.53%
SLXP Salix Pharmaceuticals Ltd3.47%
HZNP Horizon Pharma Inc3.38%
ACT Actavis PLC3.37%
MNK Mallinckrodt PLC3.36%
LCI Lannett Co Inc3.35%
LLY Eli Lilly and Co3.33%
MDCO The Medicines Company3.32%